From theheart.org on Medscape

Medscape Medical News from the:

American Heart Association (AHA) 2014 Scientific Sessions

November 15 - 19, 2014; Chicago, Illinois

The Cardiology Show

The Cardiology Show From AHA 2014 With Dr Valentin Fuster DAPT and IMPROVE-IT were the standouts from the American Heart Association 2014 Sessions, but Dr Fuster and panelists discuss lots more, including five curiosities that give pause for thought.

Meeting Highlights at a Glance

Top News From AHA 2014: Slideshow Highlights include release of long-awaited clinical trials of statins and dual antiplatelet therapy and more.

Conference News

AHA Lower Stroke Risk With Paroxysmal AF?
Medscape Medical News, December 15, 2014
AHA Gel Injected Into Left Ventricle Shows Promise in AUGMENT HF
Heartwire from Medscape, December 8, 2014
AHA No Outcomes Gain From CT Screening of Asymptomatic Diabetics
Heartwire from Medscape, December 8, 2014
AHA No SUPPORT for Adding an ARB in Stable Hypertensive CHF
Heartwire from Medscape, December 5, 2014
AHA Potassium-Binding Agent Relieves Hyperkalemia in Phase 3 Study
Heartwire from Medscape, December 4, 2014
AHA Marijuana Smoke as Damaging to Arteries as Tobacco Smoke
Heartwire from Medscape, December 3, 2014
AHA SAFETY: Boosted Home Care Cuts Hospitalization in Chronic AF
Heartwire from Medscape, December 1, 2014
AHA Real-time Monitoring Device Lowers Radiation to PCI Operators
Heartwire from Medscape, December 1, 2014
AHA Aspirin Often Used Needlessly With OACs in AF: SPRINT-AF
Heartwire from Medscape, November 27, 2014
AHA 'Mission: Lifeline' Shows Collaborative Care Ups MI Survival
Heartwire from Medscape, November 27, 2014
AHA Beta-Blocker, ARB Similarly Protective of Aorta in Marfan's
Heartwire from Medscape, November 26, 2014
AHA TOPCAT Analysis: Spironolactone Benefits HFPEF in Americas
Heartwire from Medscape, November 26, 2014
AHA Value of 'MRI-Safe' Pacemakers, ICDs Questioned in MagnaSafe
Heartwire from Medscape, November 21, 2014
AHA IMPROVE-IT: 'Modest' Benefit With Ezetimibe in Post-ACS Patients
Heartwire from Medscape, November 21, 2014
AHA AVOID Oxygen? Evidence of Harm in MI
Heartwire from Medscape, November 21, 2014
AHA WOSCOPS at 20 Years Shows 'Lifetime' Benefit of Statins
Heartwire from Medscape, November 20, 2014
AHA Added Value of Biodegradable-Polymer DES Questioned
Heartwire from Medscape, November 19, 2014

AHA Bare-Metal Stent Safety Is a 'Myth': DAPT Secondary Analysis
Heartwire from Medscape, November 19, 2014
AHA Trans Fat Linked to Worse Memory
Medscape Medical News, November 19, 2014
AHA Endocarditis Cases Rise After Predental Antibiotic Use Falls
Heartwire from Medscape, November 18, 2014
AHA No Gain Seen to Repair Added to CABG in Ischemic MR
Heartwire from Medscape, November 18, 2014
AHA BP-Medication Use Improves With Community Initiative
Heartwire from Medscape, November 18, 2014
AHA HDL Functionality Inversely Linked With CVD Events
Heartwire from Medscape, November 18, 2014
AHA Low-Dose Aspirin Fails in Primary Prevention
Medscape Medical News, November 18, 2014
AHA ODYSSEY ALTERNATIVE: PCSK9 Inhibitor for Statin Intolerance
Heartwire from Medscape, November 18, 2014
AHA Warfarin Excess in AF Patients on Aspirin Ups Dementia Risk
Heartwire from Medscape, November 17, 2014
AHA PARAMEDIC: No Advantage for Mechanical vs Manual CPR
Medscape Medical News, November 16, 2014
AHA Cholesterol Guidelines Still Stirring Debate 1 Year Later
Heartwire from Medscape, November 16, 2014
AHA Stressed Young Women With CAD Susceptible to Heart Ischemia
Heartwire from Medscape, November 16, 2014
AHA DAPT: Long-Term Dual Antiplatelets After Stenting a Risk/Benefit Balancing Act
Heartwire from Medscape, November 16, 2014
AHA Hypoxia, Hypotension 'Deadly Combo' in TBI
Medscape Medical News, November 16, 2014
AHA Persistent Asthma Linked With Cardiovascular Disease
Heartwire from Medscape, November 16, 2014
AHA AHA Sessions to Feature Long-Awaited Lipid, Stent Trials
Heartwire from Medscape, November 10, 2014

Perspectives from AHA

Social Media-Savvy Cardiologists Discuss Tips and Pitfalls
Melissa Walton-Shirley, MD; Seth Bilazarian, MD; John Mandrola, MD; Mintu Turakhia, MD
Heart Failure: AHA 2014 and Predictions for 2015
James L Januzzi, MD; Clyde W Yancy, MD
An Interview With PARADIGM HF PI, John McMurray
Ileana L Piña, MD; John JV McMurray, MB ChB (Hons), MD
AHA 2014: Lipids, Platelets, and CT Angiography Trials
Melissa Walton-Shirley, MD; E. Magnus Ohman, MD
Sharing the Gift of Knowledge, Cherishing the Gift of Trust
Ileana L. Piña, MD, MPH
DAPT: Benefits Beyond the Stent
Michelle L O'Donoghue, MD, MPH; Karol E Watson, MD, PhD
The DAPT Trial: An Interview With Laura Mauri
Samuel Z Goldhaber, MD; Laura Mauri, MD, MSc
Dual Antiplatelet Therapy: The Long and the Short of It
Seth Bilazarian, MD; Gilles Montalescot, MD, PhD
IMPROVE-IT: Are We Back to 'The Lower the Better' for LDL-C?
Seth Bilazarian, MD; Christopher P. Cannon, MD
Atenolol vs Losartan in Patients With Marfan Syndrome
Robert J. Widmer, MD, PhD; Juan Bowen, MD

Bloggers From the Floor

MagnaSafe Proves Most Device Patients Safe in MRI Scanner Dr Melissa Walton-Shirley relates the results of the MagnaSafe registry and makes a plea for healthcare providers and device makers to pay attention.
Coronary Heart Disease Survivor VP Dick Cheney Dr Melissa Walton-Shirley attended former VP Dick Cheney's press conference. Here is what she came away with.
So Many Trials, So Little Time: It's What We Do Dr Melissa Walton-Shirley recounts her busy opening day at the AHA conference, zooming from antiplatelet therapy to asthma to energy drinks to social media and more.
What I'm Telling Patients About Ezetimibe on Monday Morning Dr Melissa Walton-Shirley summarizes the points of IMPROVE-IT for her patients.
AHA 2014: Inching Forward Dr John Mandrola picks the standouts and big stories (standouts or not) from the AHA meeting this week.
Fear, Marketing, Corporate Influence, and the MagnaSafe Registry Dr John Mandrola discusses why there is an inability to accept the overwhelming evidence that MRIs are safe for nearly all patients with cardiac devices.
Day 3 AHA: The Health eHeart Study: A Digital Disruption of Clinical Research Dr John Mandrola attends a session that describes how technology can transform medical research, with a million subjects.
In Terms of Stroke Risk, Not All Atrial Fibrillation Is Created Equal For years, decades, cardiologists have considered all forms of AF, paroxysmal, persistent, or permanent, equally risky when it comes to stroke. But An abstract at AHA clearly showed, in 134 000 patients, that paroxysmal AF was lower risk then permanent AF.
Day 1 AHA: The Future of EP Is Not Bleak Dr John Mandrola attended an early-career session on choosing electrophysiology. He came away inspired and grateful. Here is his report on what two giants in the field told the next generation of doctors.

Live Blog

News and Views from AHA 2014 Coverage of key advances and expert reactions as they happened at the meeting.

Previous Coverage